IMI PLC
Investor Relations

In the bustling heart of the engineering sector, IMI PLC stands as a testament to British industrial prowess. Founded in 1862, this company has evolved significantly over the decades, moving from a local iron-foundry firm to a global leader in specialized engineering. At its core, IMI PLC excels in the creation of high-value industrial solutions focused on fluid and motion control technologies. With operations spanning the globe, it inhabits three primary divisions: Precision Engineering, Critical Engineering, and Hydronic Engineering. Each division is uniquely tailored to cater to diverse sectors, including energy, transportation, and healthcare, by offering solutions that ensure seamless operation, efficiency, and safety in various industrial processes.

IMI PLC’s business model capitalizes on its deep technical expertise and innovative edge to generate robust revenue streams. By engineering bespoke systems that enhance the performance and longevity of their clients’ operations, they build strong, long-standing relationships with leading global organizations. Notably, the Critical Engineering division shines in crafting large-scale, tailor-made safety and flow control systems critical for heavy industries, while Precision Engineering plays a crucial role in developing components integral to modern manufacturing and automation. Meanwhile, Hydronic Engineering refines climate control systems, delivering energy-efficient solutions for heating and cooling in buildings. Collectively, these divisions drive the company’s success, with IMI PLC intricately weaving innovation and industry-specific insight to foster sustainable growth and profitability.

Show more
Loading
IMI
FTSE All Share Index

Earnings Calls

2024 Q3
Oct 31, 2024
Show Transcript
Previous
Next
Anika's Strategic Shift and Revenue Guidance Highlights in Q3
2024 Q3
Oct 31, 2024

Anika's third quarter faced revenue challenges, totaling $38.8 million, down from the previous year, mainly due to lower partner revenue. Despite this, international OA Pain sales surged 7%. The company announced the sale of Arthrosurface for $10 million and is divesting Parcus Medical, focusing on its HA products. Looking ahead, Anika expects 14-19% revenue growth in its commercial channel for 2024 and a similar 12-18% increase for 2025, driven by new products like Integrity and the anticipated U.S. launch of Hyalofast in 2026. Adjusted EBITDA is forecasted between $16 million and $18 million for 2024, reflecting ongoing restructuring efforts.

Show Full Analysis

Management

Mr. Roy M. Twite
CEO & Director
No Bio Available
Mr. Jackie Hu
Chief Operating Officer
No Bio Available
Edward Hann
Head of Investor Relations
No Bio Available
Ms. Erica Lockhart
Group Communications Director
No Bio Available
Ms. Liz Rose
Chief People Officer
No Bio Available
Mr. Giuseppe Buscemi
President of Europe Oil & Gas & Power
No Bio Available
Mr. Wayne Prokop
President of Americas
No Bio Available
Mr. Martin Maas
President of Life Science & Fluid Control
No Bio Available
Mr. Nick Adcock
President of CCI
No Bio Available
Mr. Marshall Goldberg
President of Display Technologies
No Bio Available

Contacts

Address
WEST MIDLANDS
BIRMINGHAM
Lakeside, Solihull Parkway, Birmingham Business Park
Contacts
+441217173700.0
www.imiplc.com